Lee BioSolutions Inc, an international manufacturer and producer of high purity proteins and antigens announces the isolation and increased production of Acid Phosphatase and Prostate Specific Antigen. The St. Louis-based healthcare- biotechnology firm has developed a unique proprietary process to effectively and efficiently purify the prostate cancer Tumor Marker PSA and its isoforms. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components .

According to the National Cancer Institute, there is an estimated 241,000 new cases of prostate cancer in the United States along and 28,000 men will not survive this year . There is over 2.5 million men who are currently living with the disease.

Lee’s Prostate Specific Antigen production capabilities enables international diagnostics companies to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand. PSA protein that is produced by Lee Biosolutions is used in diagnostic tests which help in the diagnosis, to assess the patiences response to treatment, and allows Docters to look for recurrence.

“Lee Biosolutions is on the forefront of Prostate Cancer research by supplying highly purified markers such as PSA and its isoforms . A PSA Test measures the level of PSA in the blood and is one of the tools used for screening men with prostate cancer. With continued improvements in screening, diagnosis and treatment of prostate cancer more men are living with the disease .” said Burton Lee, President of Lee Biosolutions.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Alpha FetoProtein used in detection of liver cancer and germ cell tumors,Beta 2 Microglobulin used to detect multiple myeloma, chronic lymphocytic leukemia and some lyophomas, Thyroglobulin for detecting Thyroid Cancer, and Lactate Dehydrogenase used to assess state and prognosis of Germ cell tumors.    The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit http://www.LeeBio.com or call 314-968-1091.